Latest Headlines
-
Qosina Introduces Aramus™ 2D Bag Chambers From Entegris To Its Bioprocess Components Portfolio
7/20/2023
Qosina is pleased to announce the addition of Aramus 2D bag chambers from Entegris.
-
Sandoz Announces Plans To Build New Technical Development Center In Slovenia
7/20/2023
Sandoz, a global leader in generic and biosimilar medicines, today announced an investment of approximately USD 90 million at its site in Ljubljana, Slovenia to establish a dedicated Sandoz Biopharma Development Center by 2026.
-
Entegris And Agilitech: Transforming Single-Use Technologies
7/19/2023
Entegris announces their collaboration with Agilitech, allowing them to offer an extended line of custom, single-use systems for cell and gene therapies.
-
metabion Expands Production Capacity For Diagnostic And Therapeutic Oligonucleotides In Munich East
7/13/2023
metabion has increased its global production capacity for diagnostic and newly introduced therapeutic oligonucleotides and derivatives thereof to support the rising demand in Europe and worldwide.
- Signant Health Extends The Power Of Clinical Supply Management Software To The Small & Mid-Size Market Through Updated & Enhanced Supplies Platform 7/10/2023
-
Upcoming Webinar: People Transformation: A Practical Guide To Skilling Up People And Integrating Analytics To Deliver Business Value
7/3/2023
This webinar will explore some of the most common challenges companies have faced regarding skill up and how to navigate using datapoints derived from 100+ successful Seeq analytics training rollouts.
-
Fujifilm Appoints Lars Petersen As President & CEO Of FUJIFILM Diosynth Biotechnologies, Leading Global Bio CDMO
6/29/2023
Petersen succeeds Martin Meeson who has served as FUJIFILM Diosynth Biotechnologies president and CEO since 2020.
-
Getinge Launches New Isolator Optimized For Common Aseptic Applications
6/28/2023
Today, Getinge launches ISOPRIME; an isolator with comprehensive connectivity and traceability features. It is the ideal solution for customers looking for a rigid wall isolator that combines high quality, versatility and continuous operations at a competitive price.
-
Project Farma And Precision For Medicine Acquire Baseline Controls
6/27/2023
Precision for Medicine, the first global biomarker-driven clinical research and development organization, today announced that it has acquired Baseline Controls, a Raleigh, North Carolina-based company that provides dedicated engineers with specialized expertise in project feasibility, execution planning, and baseline performance management. Baseline Control’s expertise will become part of Project Farma, Precision for Medicine’s existing biomanufacturing strategy and execution group, expanding the scope of its manufacturing solutions for life science companies and driving greater speed and efficiency in bringing new drugs to market.
-
NIIMBL Funding Helps To Accelerate Bringing Gene Therapies To Market
6/27/2023
New funding from NIIMBL was announced to develop a viral and exotoxin clearance platform for AAV manufacturing. The goal of this project is to establish new standards and advance gene therapies.